Girish Venkataraman to CD5 Antigens
This is a "connection" page, showing publications Girish Venkataraman has written about CD5 Antigens.
Connection Strength
0.138
-
De novo CD5+ diffuse large B-cell lymphoma: Adverse outcomes with and without stem cell transplantation in a large, multicenter, rituximab treated cohort. Am J Hematol. 2016 Jun; 91(4):395-9.
Score: 0.138